Jacob Ravn

6 Patents

• US126167142026

  Enhanced Oligonucleotides for Modulating FUBP1 Expression

  Hoffmann-la Roche Inc.

  0 cites
• US124215162025

  Antisense Oligomers Targeting PCSK9

  ROCHE INNOVATION CENTER COPENHAGEN A/S

  0 cites
• US122141412025

  Method to Shift Circadian Rhythm Responsive to Future Therapy

  Timeshifter, Inc.

  0 cites
• US121041532024

  Antisense Oligonucleotide for Targeting Progranulin

  Hoffmann-la Roche Inc.

  0 cites
• US117393322023

  Antisense Oligomers Targeting PCSK9

  ROCHE INNOVATION CENTER COPENHAGEN A/S

  0 cites
• US115915942023

  LNA-G Process

  Roche Innovation Center Copenhagen A/S

  0 cites